Vegenics Pty Ltd.

Food and Medication Administration to initiate medical studies of VGX-100. The first trial will involve the treatment of a variety of different malignancy types in sufferers with late stage cancer. The IND filing can be an important milestone for all of us, since it completes our pre-scientific phase of development and transitions Circadian into a clinical development company. We be prepared to commence our first in man Phase I studies as soon as possible after FDA review. We also expect to see results from the study in the second half of 2012.The sleeve gastrectomy process has extra hormonal benefits not supplied by the Lap Band method which will help many patients curb food cravings cravings.. Blog page interviews medical researcher about proposed blueprint for AIDS-free generation THE GUTS for Global Wellness Policy’s Technology Speaks blog interviews Kenneth Mayer, founding medical research director of Fenway Wellness, within its Blueprint series, which examines issues surrounding the creation of a blueprint for an AIDS-free generation commissioned by Secretary of Condition Hillary Clinton in July. In the interview, Mayer discusses what he thinks ought to be important elements of the blueprint, highlights interventions he seems are critical the different parts of combination avoidance, and remarks on the role analysis should play in the blueprint, among various other topics .